Sewoonmedical KRX:100700KOSDAQ
세운메디칼 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked0since Sep 11
In Q2 2026, Sewoonmedical reported revenue of ₩17.7bn, up 13.0% year on year, and operating profit of ₩3.4bn. Sewoonmedical (세운메디칼) appeared in 0 Korean news articles and 0 DART filings over the past seven days.
Filing signals Revenue & profit growth Screener
Sewoonmedical quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩17.7bn | +13.0% | ₩3.4bn margin 19.4% | ₩3.4bn |
| Q1 2026 | ₩15.4bn | +5.7% | ₩3.4bn margin 22.0% | ₩3.6bn |
| Q4 2025 derived | ₩16.6bn | +10.2% | ₩3.7bn margin 22.6% | ₩3.7bn |
| Q3 2025 | ₩16.8bn | +12.4% | ₩3.8bn margin 22.3% | ₩3.9bn |
| Q2 2025 | ₩15.7bn | +2.6% | ₩2.4bn margin 15.6% | ₩1.9bn |
| Q1 2025 | ₩14.6bn | -1.9% | ₩2.8bn margin 18.9% | ₩2.8bn |
| Q4 2024 derived | ₩15.1bn | -10.1% | ₩2.3bn margin 15.5% | ₩3.4bn |
| Q3 2024 | ₩15.0bn | -16.8% | ₩2.6bn margin 17.5% | ₩2.3bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Sewoonmedical top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest Sewoonmedical news Korean headlines
No articles yet.